Montreal, Canada

Alex Cimpoia

This inventor holds 4 USPTO granted patents. Top assignee: Biochem Pharma Inc.. Active years: 1999-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alex Cimpoia. Retrieved from https://idiyas.com/inventor/alex-cimpoia-7h9igzmf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 1999-2004

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Alex Cimpoia: Innovator in Nucleoside Analogues

Introduction

Alex Cimpoia is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of biochemistry, particularly in the synthesis of nucleoside analogues. With a total of 4 patents to his name, Cimpoia's work has garnered attention in the scientific community.

Latest Patents

One of his latest patents focuses on the stereoselective synthesis of nucleoside analogues. This innovative approach has the potential to advance research in pharmaceuticals and therapeutic applications.

Career Highlights

Cimpoia is currently employed at Biochem Pharma Inc., where he continues to push the boundaries of biochemistry. His work is characterized by a commitment to developing new methodologies that enhance the efficacy of nucleoside analogues.

Collaborations

Throughout his career, Alex has collaborated with esteemed colleagues, including Tarek S Mansour and Krzysztof Bednarski. These partnerships have enriched his research and contributed to the success of his projects.

Conclusion

Alex Cimpoia stands out as a dedicated inventor whose work in nucleoside analogues is paving the way for future advancements in biochemistry. His contributions are invaluable to the field and continue to inspire innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…